Home / C16030
C16030
Recruiting

A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

Clinicaltrials.gov
#NCT04840680

About this clinical trial

In this study, people with MM will be treated with ixazomib citrate according to their clinic's standard practice. The main aim of the study is to check for side effects from ixazomib citrate.

KR
Observational clinical trial.

At a glance

What medical conditions are being studied?

Multiple Myeloma

What is the clinical trial testing?

No Intervention

How many participants are being enrolled?

165

Are placebos part of the clinical trial?

No

When is the clinical trial being conducted?

Mar 2021 - Jun 2024

How long is participation in the clinical trial?

Each participant will be in the study for about 6 months.

Key requirements

Sex

All

Age

All

Healthy volunteers?

No

Entry criteria

Both men and women can take part.
Must have multiple myeloma.
Must be being treated with ixazomib citrate according to the product label.

Locations

Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting